Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD

NCT ID: NCT06308289

Last Updated: 2024-07-23

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 68 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-03-03
• Study Completion Date: 2024-06-15

Brief Summary

The randomized controlled trial will involve 30 participants, with Group A receiving GPRM and ACBT, while Group B follows the conventional COPD model that includes ACBT only.Assessments of heart rate, physical fitness, and quality of life will contribute to a nuanced understanding of joint function, informing future COPD treatment paradigms.

Detailed Description

The focus of this study will be on addressing the critical challenge of treating chronic obstructive pulmonary disease (COPD), a globally prevalent and heterogeneous lung condition associated with substantial morbidity and mortality. With COPD anticipated to become the leading global cause of death, this research will investigate a novel intervention that combines global postural retraining (GPRM) and physical fitness, utilizing respiratory cycle technology (ACBT). This study assumes to enhance heart rate, posture, and overall quality of life in individuals with COPD. The randomized controlled trial will involve 30 participants, with Group A receiving GPRM and ACBT, while Group B follows the conventional COPD model that includes ACBT only. The study, utilizing nonprobability purposive sampling, will span six months to comprehensively evaluate cardiovascular, respiratory, and quality-of-life outcomes. Exclusion criteria ensure a representative sample, excluding individuals with severe diseases or recent surgeries. The significance of this investigation lies in its potential to revolutionize COPD treatment, offering a cost-effective approach that simultaneously enhances patient health. By targeting both biomechanical and respiratory aspects, the study aims to provide valuable insights into improving COPD treatment strategies globally, with a focus on the combined effects of global postural retraining and active breathing techniques. Assessments of heart rate, physical fitness, and quality of life will contribute to a nuanced understanding of joint function, informing future COPD treatment paradigms.

Conditions

Chronic Obstructive Pulmonary Disease

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Group A

GPRM and ACBT

Group Type: EXPERIMENTAL

Global Posture Re-education

Intervention Type: OTHER

Focusing on postural correction and movement patterns

Active Cycle of Breathing Technique

Intervention Type: OTHER

Emphasizing breathing control, thoracic expansion, and mucus clearance techniques

Group B

Standard Care for COPD (ACBT)

Group Type: ACTIVE_COMPARATOR

Active Cycle of Breathing Technique

Intervention Type: OTHER

Emphasizing breathing control, thoracic expansion, and mucus clearance techniques

Interventions

Global Posture Re-education

Focusing on postural correction and movement patterns

Intervention Type: OTHER

Active Cycle of Breathing Technique

Emphasizing breathing control, thoracic expansion, and mucus clearance techniques

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Adults aged 40-75 years diagnosed with stable COPD (according to GOLD guidelines).

2. Patients of both genders

3. FEV1: FVC ranging from 68 - 69%.

4. Predicted FEV1 of less than 70%.

5. Willingness to participate

Exclusion Criteria

1. Acute Exacerbation of COPD

2. Participants with severe comorbidities, such as unstable cardiovascular diseases (e.g., recent myocardial infarction, uncontrolled hypertension)

3. Participants diagnosed with respiratory conditions other than COPD (such as asthma, interstitial lung disease)

4. Individuals who have undergone major thoracic or abdominal surgery within the past three months

5. Individuals with severe mental health conditions (such as uncontrolled psychosis or severe depression)

6. Pregnant or lactating individuals.

• Minimum Eligible Age: 40 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Riphah International University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Muhammad Faizan Hamid, MS-CPPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Social Security Hospital

Gujranwala, Punjab Province, Pakistan

Countries

Pakistan

Other Identifiers

REC/RCR&AHS/23/0361

Identifier Type: -

Identifier Source: org_study_id